Description: Take part in an interactive session where experts from a variety of backgrounds and disciplines debate hot topics in underwriting and the impact they may have on key business outcomes such as mortality. Cast the deciding vote on each question. The debate will cover topics such as: - Leading performance indicators - are we measuring the right things? - Is the ground shifting beneath us? Less obvious, tertiary factors that could influence mortality - How much is too much? How far can we push the envelope on qualification with limited evidence? By attending the session, you will: - Identify key questions to consider relative to the continuing evolution of underwriting. - Recognize pros and cons to solutions currently in production or under consideration. - Understand potential business impacts of forthcoming underwriting changes and levers that could increase or reduce their magnitude.

Description: The use of longevity swaps are an area of growing interest in North America for insurers and pension schemes to manage their exposure to longevity risk. This growth is anticipated to continue as a consequence of the increased experience in the market and this maturity will encourage an improved affordability and ability for insurers to be flexible in this space. In Europe and Asia, longevity swaps are a much more established tool for risk transfer and optimizing asset-liability matching. From these markets, we can learn how to establish an effective framework in order to price, implement, and monitor performance of longevity swaps. By attending the session, you will be informed on the typical structure and modeling/valuation approach for longevity swaps including: - Understand longevity swap concepts, their benefits and common use. - Establish a basis for assessment such asmeasurement metrics, risk factors, and benchmarking principles. - Comprehend ongoing management such as basis risk, trigger points/pull-out clauses, potential operational issues, and asset transfer mechanisms. - Understand considerations and approach for valuing under US STAT and US GAAP.

Description: Do you know how you would handle yourself in a high visibility situation that put your professionalism in the spotlight? How would you handle being reported to the ABCD? Hear how, Tom Dlouhy, after taking a new assignment, quickly found himself challenged from many angles but came out a stronger actuary. This lunch session is a reprise of a presentation from the 2017 Seattle Life and Annuity Symposium with some new highlights. Hear Tom share his experience with the ASOPs, the ABCD, and how he attempted to maintain the high standards of actuarial professionalism.

Description: Our understanding of the biology of aging is increasing rapidly, creating insight into how and why any organism is aging. Some of the mechanisms by which the process of aging occurs in mammals are sufficiently well understood that clinical trials targeting them in humans to improve later life health and longevity are now being undertaken. Translating results seen in mammals to humans has the potential to increase life expectancy far beyond what we have seen historically. Come explore the current state and outlook of research.

Description: "Demographic components of Future Potential Old-Age Support Ratios – Kirill Andreev, Ph.D., United Nations, Population Division, New York, Mila Andreeva, KAMA Consulting Effect of internal Migration on the Health of Taiwan’s Elderly People – Jack C. Yue, Ph.D., – National Chengchi University, Department of Statistics, Taipei, TaiwanPopulation Aging and Canada’s Social Contract: Covid-19 Catalyst for Change – Douglas Andrews, FSA, FCIA, Ph.D., Lori J. Curtis, Ph.D., – University of Waterloo"

Description: "Establishing Methods for Annual Updates to Cohort Life Expectancies – R. Dale Hall, FSA, CERA, MAAAManaging Director of Research, Society of Actuaries Research Institute Longevity Disparity across Communities in the United States – Lijia Guo, Ph.D., ASA, MAAA , US Government Accountability Office, Applied Research and Methods Division, Washington DC"

Description: Both the SOA and AARP will showcase their recent research projects highlighting the impact of marginalization on aging and retirement. Learn how being a member of a marginalized group changes your outcomes as well as your perspective on aging and retirement.

Description: Mortality Model Selection and Combination in RAlternative approaches for selecting mortality models and forecasting mortality have been proposed. The usual practice is to base mortality forecasts on a single mortality model selected using in-sample goodness-of-fit measures. However, cross-validation and other alternative out-of-sample measures are increasingly being used in model selection, and model combination methods are becoming a common alternative to using a single mortality model. Such methods combine predictions from multiple mortality models to reduce model choice uncertainty and improve forecast accuracy. Explore techniques to select and combine mortality models using the freely available open source R package CoMoMo (https://github.com/kessysalvatory/CoMoMo), which extends the widely used R package StMoMo (https://CRAN.R-project.org/package=StMoMo). We will use data for the USA and other countries to discuss and demonstrate four different model combination approaches including simple model averaging, Bayesian model averaging, model confidence set, and stacked regression ensembles.

Description: "Living to 100 in the time of COVID-19: A Study of Late –Life Mortality Trajectories, Leonid A. Gavrilov, Ph.D., Natalia S. Gavrilova, Ph.D., Academic Research Centers, NORC at the University of Chicago Swedish Mortality Does Not Decelerate in Recent Cohorts, or Does it? – Roland Rau, Ph. D., Professor, University of Rostock & Max Planck Institute for Demographic Research, Rostock, Germany; Marcus Ebeling, Ph.D., Karin Modig, Ph.D., Associate Professor, Anders Ahlbom, Ph.D., Professor Emeritus, Karolinska Institute, Stockholm Sweden; Kai Kaufhold, Aktuar DAV, Ad Res Advanced Reinsurance Services GmbH, Cologne, Germany; Annika Ziegler, Lukas Stake, Hochschule Koblenz & Ad Res, Germany"

Description: "How long is long in longevity? – Jesús-Adrian Álvarez, Ph.D. - Danish Labour Market Supplementary Pension Fund (ATP), The Rate of Aging in humans is constant. New evidence – Marcus Ebeling, PhD., Research Group Mathematical and Actuarial Demography, Max Planck Institute for Demographic Research, Rostock, Germany, Department of Sociology and Demography, University of Rostock, Rostock, Germany; Roland Rau, Ph.D., Professor, Research Group Mathematical and Actuarial Demography, Max Planck Institute for Demographic Research, Rostock, Germany, C6 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Håkan Malmström, Ph.D., C6 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Anders Ahlbom, Ph.D., Professor Emeritus, Karen Modig, Ph.D., Associate Professor, C6 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden Human Lifetimes: Finite But Not Necessarily Bounded – Fei Huang, PhD., School of Risk & Actuarial Studies, UNSW Sydney; Ross Maller, Ph.D., Emeritus Professor, Xu Ning, Ph.D., Research School of Finance, Actuarial Studies & Statistics, Australian National University, Brandon Milholland, Ph.D., IQVIA Plymouth Meeting, PA."